Company: BDRX
Filing Date: 2025-05-15
Form Type: 6-K
Source: 0001214659-25-007894
Chunk: 2

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-15
Form: 6-K
Chunk 2
---
 month of May 2025 is:

| Exhibit No. |     | Description               |
| 10.1        |     | Form of Letter Agreement. |

<div align='center'>SIGNATURE</div>

Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| Date: May 15, 2025 | Biodexa Pharmaceuticals PLC 
 By:                         | /s/ Stephen Stamp                                   |
|:-------------------|:----------------------------|:----------------------------------------------------|
|                    |                             | Stephen Stamp                                       |
|                    |                             | Chief Executive Officer and Chief Financial Officer |